Listeria monocytogenes, Gram-positive anaerobic bacteria, is gaining popularity as a vector for immunotherapy of cancer. Vaccines based on modified Listeria have been created to stimulate immune responses against several types of cancer. Many clinical trials evaluating Lm cancer vaccines are now ongoing, providing insight into their potential use in cancer immunotherapy.